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Abstract Patients with congenital lack of I3 transport do not
accumulate I3 in their thyroids, often resulting in severe
hypothyroidism. A single amino acid substitution in the thyroid
Na+/I3 symporter (NIS), proline replacing threonine at position
354 (T354P), was recently identified as the cause of this
condition in two independent patients [1,2]. Here we report that
the lack of I3 transport activity in T354P NIS generated by site-
directed mutagenesis, is not due to a structural change induced by
proline, but rather to the absence of a hydroxyl group at the
L-carbon of the amino acid residue at position 354. Hence, this
hydroxyl group is essential for NIS function.
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1. Introduction
Iodide uptake into thyroid cells, the ¢rst step in the biosyn-
thesis of the iodide-containing thyroid hormones T3 and T4, is
mediated by the Na/I3 symporter (NIS). The cDNA encod-
ing NIS was cloned in our laboratory [3,4], leading to numer-
ous signi¢cant advances in NIS characterization (recently re-
viewed in [5,6]). Several cases of the rare genetic condition
known as ‘iodide trapping defect’ or ‘congenital lack of I3
transport’ have been documented over the years [7,8]. Diag-
nosis is usually made in patients who exhibit coexistence of
goiter with congenital hypothyroidism, low or absent thy-
roidal I3 uptake, and little or no I3 uptake by the salivary
glands and gastric mucosa [7,8]. The availability of the rat
and human NIS cDNAs [3,9] has made it possible for the ¢rst
time to examine the molecular basis of this defect, and an
identical mutation in NIS has recently been reported in two
di¡erent patients. Fujiwara et al. [1] identi¢ed a homozygous
missense mutation in a hypothyroid patient with an I3 trans-
port defect. They found Pro instead of Thr at position 354
(T354P). Transfection of the mutant T354P NIS cDNA into
human embryonic kidney (HEK)-293 cells did not elicit any
I3 uptake activity. Hence, on this basis, the authors proposed
that T354P probably disrupts, through a structural change,
the ninth putative transmembrane helix of NIS, where the
amino acid substitution is located.
More recently, Matsuda et al. [2] reported another case of
an I3 transport defect with a loss of function mutation in the
NIS gene. Strikingly, as noted above, this mutation is exactly
the same as that in Fujiwara’s report, i.e. T354P. The patient
was euthyroid, apparently due to an extremely high I3 dietary
intake, but he exhibited greatly increased NIS mRNA levels in
his thyroid, and a slightly increased level of thyroid stimulat-
ing hormone (TSH) at the time of the open thyroid biopsy.
This patient was born from a consanguineous marriage, and
his daughter was heterozygous for the mutation but had no
abnormal phenotype, suggesting the recessive nature of the
disease. It is of considerable interest to compare these two
cases. First, the comparison illustrates the variety of pheno-
types that can be found for this condition, as one of the
patients was hypothyroid and the other largely euthyroid.
Second, whereas Fujiwara et al. [1] observed no I3 transport
activity when they transfected the cDNA bearing the T354P
mutation into HEK-293 cells, Matsuda et al. [2] reported a
low but measurable and potentially signi¢cant level of activity
(0.4% with respect to wild-type NIS). These authors proposed
that the overexpression of NIS transcript in this patient’s
thyroid may result in a compensatory mechanism whereby
the patient’s intake of extremely large amounts of I3 produces
a euthyroid phenotype. Moreover, both patients come from
the same region in Japan, and thus the possibility that they
share a common ancestor deserves to be explored.
NIS protein levels were not measured in either study, pre-
sumably due to the unavailability of anti-NIS antibodies
(Abs) or enough thyroid tissue. Therefore, the mechanism
by which these NIS mutations result in a loss of I3 uptake
remained unknown. Hence, to characterize this transport de-
fect at the molecular level, we sought to determine whether
T354P NIS is a non-functional but stable polypeptide prop-
erly targeted to the plasma membrane, or a fully or partially
functional protein that is retained in intracellular organelles as
a result of the mutation, as is the case with some mutations in
CFTR [10] and SGLT-1 [11] transporters.
2. Materials and methods
2.1. Site-directed mutagenesis
The following individual mutagenic oligonucleotides were generated
to make the following substitutions at the threonine-354 position:
T354P: CACCCTCAGCCCTGCATCCACC; T354G: CACCCTC-
AGCGGTGCATCCACC; T354A: CACCCTCAGCGCTGCATCC-
ACC; T354Y: CACCCTCAGCTACGCATCCACC; T354S: CAC-
CCTCAGCTCCGCATCCACC; T354C: CACCCTCAGCTGTGC-
ATCCACC. The initial PCR extensions were performed using reverse
primers complementary to the 3P end. These fragments were gel pu-
ri¢ed and used for a second round PCR extension with primers
complementary to the 5P end. Fragments with the mutant sequences
were obtained by digesting the ¢nal PCR products with the appro-
priate unique restriction enzymes that would yield the smallest mutant
fragments. These fragments were ligated into wild-type NIS cDNA
and the mutant inserts were sequenced past their respective cloning
sites.
FEBS 20287 8-6-98 ^ Pagina 36 Cyaan Magenta Geel Zwart
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 0 5 2 2 - 5
*Corresponding author. Fax: (1) (718) 430 8922.
E-mail: carrasco@aecom.yu.edu
FEBS 20287FEBS Letters 429 (1998) 36^40
2.2. Transfection of COS cells with NIS cDNA
COS cells were cultured and transfected as previously reported [3].
Brie£y, COS cells were transfected by the DEAE-Dextran method
with 3 Wg/10-cm plate NIS cDNA in pSV.SPORT (Gibco-BRL) and
two days post-transfection were assayed for iodide uptake as previ-
ously reported [3], and by immunoblot analysis.
2.3. Membrane preparations from NIS-expressing COS cells
Membranes from COS cells (10-cm plate) were isolated with pro-
tease inhibitors as described [12], except that after the centrifugation
to remove nuclei the supernatant was incubated with 0.1 M Na2C03,
pH 11.2, for 45 min shaking at 4‡C prior to high speed centrifugation
at 100 000Ug to pellet membranes. Protein determination was per-
formed as described [12].
2.4. Immunoblot analysis
SDS-9% PAGE and electroblotting to nitrocellulose were per-
formed as previously described [12]. All samples were diluted 1:2
with sample bu¡er and heated at 37‡C for 30 min prior to electro-
phoresis. Immunoblot analyses were also carried out as described [12],
with a⁄nity puri¢ed anti-NIS Ab at 3 Wg/blot and a 1:1500 dilution
of a horseradish peroxidase-linked donkey anti-rabbit IgG (Amer-
sham). Both incubations were performed for 1 h. Proteins were vis-
ualized by enhanced chemiluminescence (ECL) Western blot detection
system (Amersham).
2.5. Immuno£uorescence of COS cells expressing T354 NIS
substitutions
COS cells were seeded onto polylysine coated cover slips one day
after transfection (V50%). On the second day after transfection cells
were ¢xed with 4% paraformaldehyde for 10 min, then washed 3 times
with PBS. Cells were permeabilized with methanol for 5 min and
washed 3 times with PBS. Cells were then blocked with 4% BSA/
PBS for 1 h and subsequently incubated with a⁄nity puri¢ed anti-
NIS Ab (6 Wg/Wl) at 1:500 dilution in 4% BSA/PBS for 1 h. Cells were
washed three times for 5 min with 0.2% Tween-20 in PBS and once
with PBS only. Cover slips were then transferred onto 150 Wl PBS
containing goat anti-rabbit £uorescein conjugated secondary Ab
(1:100 dilution) (Pierce) for 1 h in the dark and then washed as above.
Cover slips were air-dried for 3 min and were then mounted onto
slides containing 15 Wl PBS in 50% glycerol with phenylenediamine.
Cover slips were sealed with quick dry nail-polish and allowed to dry
in the dark for 2 h at room temperature and then stored at 4‡C in the
dark. Cells were visualized in a BioRad MRC600 Laser Scanning
confocal microscope equipped with a 60U oil immersion objective
lens. Epi£uorescent and £uorescent video images were collected, en-
hanced and analyzed using graphics software.
3. Results and discussion
3.1. Characterization of activity and expression of T354P
in transfected COS cells
Having recently obtained a high a⁄nity anti-NIS Ab
against (rat) NIS [12], we decided to generate T354P (rat)
NIS by site-directed mutagenesis and use the Ab to monitor
T354P expression in COS cells. COS cells transfected with
T354P NIS cDNA were assayed for I3 uptake activity as
described [3], and found to display no I3 accumulation (Fig.
1A). Thus, these cells were indistinguishable from control
non-transfected COS cells (Fig. 1A), which lack an endoge-
nous I3 accumulating system [3,4]. In contrast, COS cells
expressing wild-type (WT) NIS accumulated V22 pmol I3/
Wg DNA, which was inhibitable by perchlorate (ClO34 ) (Fig.
1A, [3]). These data are consistent with the reported lack of I3
uptake in both HEK and COS cells expressing human T354P
cDNA [1,2]. To assess whether the lack of I3 uptake activity
in cells transfected with T354P cDNA was due to the absence
of T354P expression, membranes from transfected COS cells
were analyzed by immunoblot analysis using anti-NIS Ab. As
we have previously shown [12], anti-NIS Ab recognizes 65-
kDa and 90-kDa NIS polypeptides (di¡ering from each other
only in the degree of N-linked glycosylation) in COS cells
expressing wild-type NIS. Remarkably, the levels of T354P
observed upon immunoblot analysis of membranes from
T354P-transfected COS cells were virtually identical to wild-
type NIS (Fig. 1B, compare WT NIS to T354P). Therefore,
T354P generated by site-directed mutagenesis is expressed in
transfected COS cells, even though these cells exhibit no I3
transport activity. To determine whether T354P was properly
targeted to the plasma membrane, we analyzed by indirect
immuno£uorescence with anti-NIS Ab both T354P and
wild-type transfected cells. Comparable plasma membrane-as-
sociated staining was observed in both wild-type and T354P
transfected cells (Fig. 1C, panel E). Staining in both wild-type
and T354P transfected cells was absent when cells were
not permeabilized (Fig. 1C, panels A and D), and also in
permeabilized cells incubated with excess C-terminal peptide
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Fig. 1. Characterization of activity and expression of T354P NIS in
transfected COS cells. A: Non-transfected COS cells (NT) or COS
cells transfected either with WT or T354P NIS were assayed for
iodide transport activity as reported [3] two days after transfection.
Assays were performed in the presence of Na (solid bars) and Na
plus perchlorate (clear bars). Shown are triplicate determinations of
iodide uptake at the 45-min time point of a representative experi-
ment (n = 6). B: Membranes were isolated from transfected COS
cells, 20 Wg were electrophoresed on SDS-9% PAGE and electro-
transferred and immunoblotted with anti-NIS Ab as described previ-
ously [12]. C: Immuno£uorescence of WT and T354P NIS trans-
fected COS cells was performed as described in Section 2. All
coverslips were incubated with anti-NIS and £uorescein conjugated
goat anti-rabbit Abs. Top panels (A), non-permeabilized cells ; mid-
dle panels (B), cells permeabilized with methanol; and bottom pan-
els (C), cells permeabilized with methanol and incubated in the pres-
ence of C-terminal peptide (100 Wg).
O. Levy et al./FEBS Letters 429 (1998) 36^40 37
against which the Ab was raised (Fig. 1C, panels C and F),
con¢rming that T354P is properly targeted to the plasma
membrane.
3.2. E¡ect of other T354 substitutions on NIS expression and
activity in COS cells
As indicated above, Fujiwara et al. [1] have suggested that
the presence of Pro in place of Thr at position 354 induces a
kink in the ninth putative transmembrane helix of NIS, thus
conceivably explaining the lack of activity. To test this notion,
we examined the possible role played by amino acids that
stabilize or destabilize the K-helix. By site-directed mutagene-
sis we alternatively placed an Ala (an K-helix-stabilizer resi-
due) or a Gly (an K-helix destabilizer residue) at position 354
instead of the original Thr. Interestingly, either substitution
yielded a normally expressed (Fig. 2B) but non-functional NIS
protein (Fig. 2A), indicating that the major factor causing the
loss of function is the absence of Thr itself, rather than any
structural e¡ect on the K-helix that might result from the
presence of either Pro or Gly at position 354.
This observation raised the possibility that, more speci¢-
cally, the hydroxyl group of Thr is important for function,
and that its loss renders the protein non-functional. To exam-
ine this hypothesis, we alternatively substituted T354 with two
di¡erent hydroxyl-containing amino acids, Tyr and Ser. Like
T354P, T354Y was non-functional and normally expressed
(Fig. 2A,B), whereas T354S was completely functional and
inhibitable by perchlorate, just like wild-type NIS (Fig.
2A,B). Indeed, the position of the hydroxyl group in Ser is
far more similar to Thr than Tyr. In both Thr and Ser the
hydroxyl group is at the L-carbon of the amino acid, whereas
the hydroxyl group in Tyr is at the B-carbon of the side chain
phenyl group and consequently further away from the L-car-
bon of that amino acid. These data show speci¢cally that the
presence of a hydroxyl group in close proximity to the L-
carbon of the residue at position 354 is essential for NIS
function, a requirement satis¢ed either by the original Thr
or by Ser. Moreover, a non-functional but normally expressed
protein resulted when Cys was substituted for Thr at position
354 (T354C) (Fig. 2A,B), even though Cys is isosteric with
Ser. The e¡ect of the Cys substitution is due to the presence in
this residue of a thiol (SH) instead of a hydroxyl group next
to the L-carbon, underlining the signi¢cance of the hydroxyl
group close to the L-carbon of the 354 residue for NIS func-
tion. Furthermore, comparable plasma membrane-associated
£uorescence was observed in COS cells expressing all de-
scribed substitutions at T354, demonstrating that all these
T354 mutants are properly targeted to the plasma membrane
(Fig. 2C, all B panels).
3.3. Concluding remarks
In summary, we have determined with an anti-NIS anti-
body that T354P protein is expressed and properly targeted
to the plasma membrane in COS cells transfected with this
mutant. Therefore, we predict from these results that patients
bearing this mutation properly synthesize and target mutant
T354P. It will be of interest to assess levels of T354P protein
and its localization in thyroid cells from patients bearing this
mutation. We conclude further that the presence of Pro at
position 354 does not render the transporter inactive as a
result of a structural change in the K-helix, given that the
T354A (an K-helix-stabilizer residue) substitution also yields
an inactive NIS. Substitution of Thr354 with Ser results in fully
active NIS, underlining the importance of the hydroxyl side
chain at position 354 for NIS activity. More speci¢cally, we
have demonstrated that the presence of a hydroxyl group near
the L-carbon of the residue at position 354 is essential for NIS
function.
It is noteworthy that many serine and threonine residues
are present every second or third residue in the putative trans-
membrane helix 9 of NIS (Fig. 3). The hydroxyl side chain at
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Fig. 2. E¡ect of other T354 substitutions on NIS expression and ac-
tivity. A: COS cells were transfected with: lane 1, T354G; lane 2,
T354A; lane 3, T354S; lane 4, T354Y; or lane 5, T354C NIS and
assayed for iodide transport activity as reported [3] two days after
transfection. Assays were performed in the presence of Na (solid
bars) and Na plus perchlorate (clear bars). Shown are triplicate de-
terminations of iodide uptake at the 45-min time point (n = 6).
B: Membranes were isolated from transfected COS cells, 20 Wg were
electrophoresed on SDS-9% PAGE, electrotransferred and immuno-
blotted with anti-NIS Ab as described previously [12]. C: Immuno-
£uorescence of T354 substitution transfected COS cells was per-
formed as described in Section 2 and as indicated in the legend to
Fig. 1C.
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position 354 could possibly play a role in the translocation of
Na, and together with the cluster of serine and threonine
residues present in helix 9, these hydroxyl groups could be
involved in the Na binding, translocation or coupling do-
mains (Fig. 3). Supporting this notion is the fact that T354
is conserved in several Na-dependent cotransporters and has
been postulated to be in a ‘hot spot’ for mutations [1]. An-
other NIS mutation has recently been reported [13], in which
a stop codon was identi¢ed at position 272 (NIS 272X), re-
sulting in a truncated NIS molecule. However, NIS 272X
protein measurements were not performed due to the unavail-
ability of anti-NIS Abs against the ¢rst half of the NIS mol-
ecule [13]. It is clear that the identi¢cation and characteriza-
tion of other NIS mutations resulting in inactive transporters,
combined with continued testing of the NIS secondary struc-
ture model, are likely to provide further insight into the pre-
cise mechanism of Na and I3 translocation catalyzed by
NIS.
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